RxDoctor Payments Data

Thomas Sangiovanni, MD

Foot and Ankle Surgery · Coral Gables, FLNPI 1518932896

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (45.2%), ownership interests and consulting fees — rather than concentrated in one kind of arrangement. Paragon 28, Inc. accounts for 94.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2020 at $959,570 and has fallen 95.4% since, to $43,729 in 2025. Among foot and ankle surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,119,963in general payments, 2019–2025

Across 329 payments — averaging $6443.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$2M
  • Avitus Orthopaedics, Inc.$49K
  • Zimmer Biomet$21K
  • Stryker$20K
  • Anika Therapeutics, Inc.$18K
  • Southern Edge Orthopaedics, Inc.$4K
  • plus $3K from 12 others
$4,245in research payments, 2019–2025

Across 3 payments — averaging $1415.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Paragon 28, Inc.$4K

What the payments were for

  • Royalty or licence$957,37045%
  • Consulting fees$424,48220%
  • Travel & lodging$55,2423%
  • Food & beverage$8,2280%
  • Education$21,9991%
  • Ownership interest$648,96031%
  • Other$3,6840%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Paragon 28, Inc.243$2,005,900
Avitus Orthopaedics, Inc.10$49,095
Zimmer Biomet22$20,525
Stryker(2 entities)7$19,658
Anika Therapeutics, Inc.5$17,802
Southern Edge Orthopaedics, Inc.5$3,562
Arthrex17$1,538
Citieffe, Inc.1$460
Ossio Inc3$412
Integra Lifesciences Corporation4$377
UOC USA Inc1$188
Think Surgical, Inc.1$148
Smith+Nephew4$91
Additive Orthopaedics, LLC1$70
DJO, LLC2$51
Bone Support Inc.1$50
Fidia Pharma USA Inc.1$21
Bioventus LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,119,963 in reported general payments places this provider in the 95th percentile of 850 foot and ankle surgery providers in Florida.

See all foot and ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$47,752
Medicare patients
96
Services billed
418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other foot and ankle surgery in Coral Gables

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →